SCHEMBL12284231

SCHEMBL12284231

COc1cc(C=O)c(N2CCC(CNC(=O)OC(C)(C)C)C2)cc1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SUV39H2 Q9H5I1 3/20 0.48
▸ CKS1B P61024 1/20 0.42
▸ SKP1 P63208 1/20 0.42
▸ SKP2 Q13309 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ GFER P55789 1/20 0.42
▸ MCL1 Q07820 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ ACACB O00763 5/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28648284 0.85 CKS1B (0.45) SUV39H2CKS1BSKP1SKP2ACACB
SCHEMBL12282868 0.83 PIM1 (0.55) SUV39H2
SCHEMBL12284284 0.82 PIM1 (0.51) SUV39H2
SCHEMBL12284239 0.82 PIM1 (0.51) SUV39H2
SCHEMBL12283371 0.82 PIM1 (0.51) SUV39H2
SCHEMBL28926895 0.79 CKS1B (0.49) SUV39H2CKS1BSKP1SKP2KDM4E
SCHEMBL2427187 0.77 ALDH1A1 (0.52) SUV39H2ALDH1A1MAPTKDM4ECYP3A4
SCHEMBL13537832 0.76 CKS1B (0.46) SUV39H2CKS1BSKP1SKP2ALDH1A1
SCHEMBL13537836 0.76 CKS1B (0.46) SUV39H2CKS1BSKP1SKP2ALDH1A1
SCHEMBL12283725 0.75 DRD2 (0.53) SUV39H2CKS1BSKP1SKP2ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150051185-A1 Chemical Compounds 251 ASTRAZENECA AB (SE) 2015-02-19 — — US disclosed
US-20150051185-A1 Chemical Compounds 251 ASTRAZENECA AB (SE) 2015-02-19 — — US disclosed
US-8901307-B2 Chemical compounds 251 ASTRAZENECA AB (SE) 2014-12-02 — — US disclosed
US-8901307-B2 Chemical compounds 251 ASTRAZENECA AB (SE) 2014-12-02 — — US disclosed
US-20110218182-A1 CHEMICAL COMPOUNDS 251 ASTRAZENECA AB (SE) 2011-09-08 — — US disclosed
US-20110218182-A1 CHEMICAL COMPOUNDS 251 ASTRAZENECA AB (SE) 2011-09-08 — — US disclosed
WO-2010001169-A2 CHEMICAL COMPOUNDS 251 ASTRAZENECA AB (SE) 2010-01-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110218182-A1 CHEMICAL COMPOUNDS 251 PIM1, PIM3, PIM2 SUV39H2 1546/4885CKS1B 264/4885SKP1 406/4885
US-20150051185-A1 Chemical Compounds 251 PIM1, PIM3, PIM2 SUV39H2 1721/4885CKS1B 271/4885SKP1 510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback